Metropolitan Life Insurance CO Vir Biotechnology, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $2,678 - $7,213	293 Added 6.4%	4,869 $45,000
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $106,163 - $124,879	4,576 New	4,576 $112,000
Q4 2022 Jun 14, 2023	BUY	$19.96 - $28.22 $87,464 - $123,660	4,382 New	4,382 $111 Million
Q3 2022 Jun 14, 2023	BUY	$18.26 - $31.1 $80,015 - $136,280	4,382 New	4,382 $84.5 Million
Q2 2022 Jun 20, 2023	BUY	$19.08 - $26.7 $83,608 - $116,999	4,382 New	4,382 $111,000
Q2 2022 Mar 30, 2023	BUY	$19.08 - $26.7 $9,005 - $12,602	472 Added 12.07%	4,382 $111,000
Q2 2022 Aug 11, 2022	BUY	$19.08 - $26.7 $9,005 - $12,602	472 Added 12.07%	4,382 $112,000
Q1 2022 Jun 20, 2023	BUY	$21.19 - $40.01 $82,852 - $156,439	3,910 New	3,910 $100,000
Q1 2022 Mar 30, 2023	SELL	$21.19 - $40.01 $244,405 - $461,475	-11,534 Reduced 74.68%	3,910 $100,000
Q1 2022 May 12, 2022	SELL	$21.19 - $40.01 $244,405 - $461,475	-11,534 Reduced 74.68%	3,910 $101,000
Q4 2021 Jun 21, 2023	BUY	$30.97 - $54.03 $478,300 - $834,439	15,444 New	15,444 $646,000
Q4 2021 Mar 30, 2023	SELL	$30.97 - $54.03 $25,612 - $44,682	-827 Reduced 5.08%	15,444 $646,000
Q4 2021 Feb 15, 2022	SELL	$30.97 - $54.03 $25,612 - $44,682	-827 Reduced 5.08%	15,444 $647,000
Q3 2021 Jun 21, 2023	BUY	$34.9 - $54.54 $567,857 - $887,420	16,271 New	16,271 $708,000
Q2 2021 Mar 30, 2023	BUY	$38.75 - $51.0 $48,321 - $63,597	1,247 Added 8.3%	16,271 $769,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $629,920 - $829,056	16,256 Added 108373.33%	16,271 $769,000
Q1 2021 Jun 26, 2023	BUY	$26.34 - $83.07 $395,732 - $1.25 Million	15,024 New	15,024 $770 Million
Q1 2021 Mar 30, 2023	SELL	$26.34 - $83.07 $17,568 - $55,407	-667 Reduced 4.25%	15,024 $770,000
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $412,905 - $1.3 Million	-15,676 Reduced 99.9%	15 $770,000
Q4 2020 Jun 22, 2023	BUY	$25.51 - $43.38 $400,277 - $680,675	15,691 New	15,691 $420,000
Q3 2020 Jun 26, 2023	BUY	$28.28 - $53.6 $443,741 - $841,037	15,691 New	15,691 $538,000
Q3 2020 Mar 30, 2023	BUY	$28.28 - $53.6 $41,769 - $79,167	1,477 Added 10.39%	15,691 $538,000
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $41,769 - $79,167	1,477 Added 10.39%	15,691 $539,000
Q2 2020 Jun 26, 2023	BUY	$27.89 - $47.86 $396,428 - $680,282	14,214 New	14,214 $582,000
Q2 2020 Mar 30, 2023	BUY	$27.89 - $47.86 $326,731 - $560,679	11,715 Added 468.79%	14,214 $582,000
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $326,731 - $560,679	11,715 Added 468.79%	14,214 $582,000
Q1 2020 Jul 12, 2023	BUY	$12.04 - $60.2 $30,087 - $150,439	2,499 New	2,499 $85,000
Q1 2020 Mar 30, 2023	SELL	$12.04 - $60.2 $22,671 - $113,356	-1,883 Reduced 42.97%	2,499 $85,000
Q1 2020 May 15, 2020	BUY	$12.04 - $60.2 $30,087 - $150,439	2,499 New	2,499 $86,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$116 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$114 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$91.3 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$39.1 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$24.8 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account